HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Michael Rossi, the Company’s chief financial officer and treasurer, effective December 31, 2022. The Company has appointed Jennifer Cote, the Company’s vice president of global finance, as its interim chief financial officer and treasurer, effective upon Mr. Rossi’s resignation. Mr. […]

Next to the company founders, Dr. Wilhelm Kaenders (also Managing Director TOPTICA Photonics AG) and Dr. Frank Lison (Managing Director TOPTICA Projects,) Armin Zach will become responsible for research and technology. TOPTICA Projects has been spun-off from TOPTICA Photonics AG as a separate entity in 2016. Armin Zach has been one of the start-up members […]

INDIANAPOLIS – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of Brad Moore as president and CEO of Roche Diagnostics North America, effective January 1, 2023. Moore currently serves as senior vice president, Core Lab and Point of Care, within Roche Diagnostics North America. Moore will succeed and report to Matt Sause, who […]

Rockville, MD — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell–engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announces the appointment of Patrick J. Balthrop, Sr. to the company’s Board of Directors as non-executive director with immediate effect. Mr. Balthrop is also […]

Maravai announces plans for William “Trey” Martin, III to serve as President of its Biologics Safety Testing Segment and its expectation that he will then assume the role of Maravai’s CEO in July 2023 Carl Hull to continue to serve as Executive Chairman and Interim CEO SAN DIEGO — Maravai LifeSciences, Inc. (NASDAQ: MRVI), a […]

MENLO Park – LevitasBio, Inc., a premier end-to-end sample processing and cellular analysis provider to the life sciences market, announced the hiring of Dominique Remy-Renou as its Senior Vice President of Global Commercial Operations of LevitasBio Europe BV, and the appointment of Greg Herrema to its Board of Directors. The addition of two Life Sciences […]

Appointments of Business Development Manager and Senior Product Manager follow move to state-of-the-art new facilities at Oxford Technology Park Expansion of team will support over 30 new products in the pipeline Oxford, UK: The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics […]

New role will lead technology development as the Company continues to scale team and global business operations Appointment of former Merck, Sharp and Dohme (MSD) Director of R&D Analytics supports continued innovation of Optibrium’s AI drug discovery software Cambridge, UK and Cambridge, US – Optibrium, a leading developer of software and AI solutions for drug discovery, […]

MILFORD, Mass. — Waters Corporation (NYSE:WAT) today announced the appointment of Dan Brennan and Mark Vergnano, to its Board of Directors, effective November 23, 2022. Mr. Brennan currently serves as Executive Vice President and Chief Financial Officer of Boston Scientific Corporation, a global medical device company, and Mr. Vergnano is the former Chairman, President and […]